Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease

This publication has 34 references indexed in Scilit:

• Fenofibrate lowers blood pressure in two genetic models of hypertension
  Canadian Journal of Physiology and Pharmacology, 2000
• Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
  Journal of Clinical Investigation, 1999
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
  The American Journal of Cardiology, 1998
• Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ1-HDL
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• High density lipoproteins and coronary heart disease
  Atherosclerosis, 1996
• Homozygous Tangier disease and cardiovascular disease
  Atherosclerosis, 1994
• Lipids and risk of coronary heart disease The Framingham Study
  Annals of Epidemiology, 1992
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease
  The American Journal of Cardiology, 1983